PubRank
Search
About
Shoji Yamaoka
Author PubWeight™ 76.01
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation.
Nat Cell Biol
2009
6.62
2
Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
Mol Cell
2003
4.37
3
Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages.
Arterioscler Thromb Vasc Biol
2006
4.07
4
Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling.
Nat Immunol
2006
4.01
5
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta.
Nature
2004
3.19
6
Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1.
Nat Immunol
2006
2.85
7
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
J Biol Chem
2003
2.69
8
Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1.
Cell Host Microbe
2012
2.48
9
Activation of NF-kappaB by HTLV-I and implications for cell transformation.
Oncogene
2005
2.10
10
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
J Clin Invest
2003
1.92
11
A20 is a negative regulator of IFN regulatory factor 3 signaling.
J Immunol
2005
1.63
12
NEMO trimerizes through its coiled-coil C-terminal domain.
J Biol Chem
2002
1.41
13
Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
J Biol Chem
2003
1.34
14
Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription.
J Biol Chem
2002
1.30
15
Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells.
Blood
2008
1.30
16
Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti.
Hum Mol Genet
2007
1.25
17
BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.
PLoS Pathog
2009
1.24
18
Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.
Trends Cell Biol
2006
1.22
19
The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains.
J Biol Chem
2004
1.11
20
Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines.
J Virol
2011
1.11
21
Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents.
Gastroenterology
2012
1.04
22
NEMO oligomerization in the dynamic assembly of the IkappaB kinase core complex.
FEBS J
2007
1.04
23
Lymphotoxin-beta receptor mediates NEMO-independent NF-kappaB activation.
FEBS Lett
2002
1.02
24
A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly.
J Virol
2013
0.99
25
Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells.
Neoplasia
2004
0.99
26
Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300.
Virology
2008
0.96
27
Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB.
J Biol Chem
2007
0.96
28
CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells.
J Biol Chem
2010
0.94
29
Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.
J Biol Chem
2011
0.93
30
Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication.
Microbes Infect
2008
0.93
31
Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
Hepatology
2013
0.92
32
HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.
PLoS One
2013
0.91
33
Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
Hum Mol Genet
2010
0.90
34
Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
Lung Cancer
2010
0.88
35
Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways.
J Biol Chem
2009
0.88
36
Role for protein geranylgeranylation in adult T-cell leukemia cell survival.
Exp Cell Res
2008
0.87
37
Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
Oncogene
2005
0.87
38
An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.
Cancer Sci
2011
0.87
39
Zinc-finger antiviral protein mediates retinoic acid inducible gene I-like receptor-independent antiviral response to murine leukemia virus.
Proc Natl Acad Sci U S A
2013
0.86
40
A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV.
Microbes Infect
2008
0.86
41
Protein kinase C-associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester.
J Biol Chem
2002
0.86
42
An alternative splice product of IkappaB kinase (IKKgamma), IKKgamma-delta, differentially mediates cytokine and human T-cell leukemia virus type 1 tax-induced NF-kappaB activation.
J Virol
2006
0.84
43
Prompt tumor formation and maintenance of constitutive NF-kappaB activity of multiple myeloma cells in NOD/SCID/gammacnull mice.
Cancer Sci
2004
0.83
44
Pycnogenol, a procyanidin-rich extract from French maritime pine, inhibits intracellular replication of HIV-1 as well as its binding to host cells.
Jpn J Infect Dis
2008
0.82
45
Upregulation of MUC6 mucin gene expression by NFkappaB and Sp factors.
Biochem Biophys Res Commun
2005
0.81
46
Identification of CD44 as a downstream target of noncanonical NF-κB pathway activated by human T-cell leukemia virus type 1-encoded Tax protein.
Virology
2011
0.81
47
Efficient induction of HIV-1 replication in latently infected cells through contact with CD4+ T cells: involvement of NF-kappaB activation.
Virology
2007
0.81
48
Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Cell Signal
2004
0.78
49
A recessive mutant cell line with a constitutive IkappaB kinase activity.
FEBS Lett
2002
0.78
50
NF-kappaB is required for cell death induction by latent membrane protein 1 of Epstein-Barr virus.
Cell Signal
2003
0.78
51
Distinct IkappaB kinase regulation in adult T cell leukemia and HTLV-I-transformed cells.
Exp Cell Res
2005
0.77
52
Anti-trypanosomal activity of diarylheptanoids isolated from the bark of Alnus japonica.
Am J Chin Med
2014
0.77
53
Inhibition of IkappaB kinase beta restrains oncogenic proliferation of pancreatic cancer cells.
J Med Dent Sci
2008
0.77
54
Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I-encoded Tax protein.
Virology
2007
0.76
55
Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
Genes Cells
2012
0.75
56
Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
PLoS One
2017
0.75
57
[Two research projects on infectious diseases conducted in Noguchi Memorial Institute for Medical Research, University of Ghana by Tokyo Medical and Dental University].
Uirusu
2013
0.75
58
[Aberrant NF-kappaB2/p52 generation in Hodgkin lymphoma cells].
Nihon Rinsho
2007
0.75